The Case for Clinical Trials with Novel GABAergic Drugs in Diabetes Mellitus and Obesity
Obesity and diabetes mellitus have become the surprising menaces of relative economic well-being worldwide. Gamma amino butyric acid (GABA) has a prominent role in the control of blood glucose, energy homeostasis as well as food intake at several levels of regulation. The effects of GABA in the body...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI AG
2022-02-01
|
| Edice: | Life |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/2075-1729/12/2/322 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|